| Brazil Potash Provides Third Quarter 2026 Update as Construction Readiness and Financing Strategy Advance |
Globe Newswire |
11/05 |
07:00 |
| Lantheus Reports Third Quarter 2026 Financial Results |
Globe Newswire |
11/05 |
07:00 |
| Orion Reports 9% Revenue Increase in Second Quarter FY2027; Reiterates Revenue Expectation of $100M-$102M for Full Fiscal Year |
Globe Newswire |
11/05 |
07:00 |
| NetraMark's NetraAI Solution is Named Analytics Platform of the Year in the 2026 BioTech Breakthrough Awards |
Globe Newswire |
11/05 |
07:00 |
| Azora Therapeutics Appoints Board of Directors with Extensive Drug Development and Inflammatory Bowel Disease Expertise |
Globe Newswire |
11/05 |
07:00 |
| CareCloud Delivers Most Profitable Quarter in Company History: Record GAAP Net Income, Record GAAP EPS and Record adjusted EBITDA |
Globe Newswire |
11/05 |
07:00 |
| Tecnoglass Reports Third Quarter 2026 Results |
Globe Newswire |
11/05 |
07:00 |
| Fate Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates |
Globe Newswire |
11/05 |
07:00 |
| Climb Bio Reports Third Quarter 2026 Financial Results and Provides Business Updates |
Globe Newswire |
11/05 |
07:00 |
| Kayak Therapeutics Announces IND Clearance for KT-300, a Potential First-in-Class TRIM7 Inhibitor for RAS-Driven Cancers |
Globe Newswire |
11/05 |
07:00 |
| Herantis Pharma: newly published clinical evidence validates HER-096 Phase 2 study design |
Globe Newswire |
11/05 |
07:00 |
| Vima Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial for Parkinson’s Disease Tremor Insufficiently Responsive to Dopaminergic Therapy |
Globe Newswire |
11/05 |
07:00 |
| Planning to Enroll at National University? How Financial Aid Timing Works and Steps to Take Before Classes Start |
Globe Newswire |
11/05 |
07:00 |
| Zenas BioPharma Reports Third Quarter 2026 Financial Results and Provides Corporate Update |
Globe Newswire |
11/05 |
07:00 |
| Korsana Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Update |
Globe Newswire |
11/05 |
07:00 |
| Enviri Corporation Reports Third Quarter 2026 Results |
Globe Newswire |
11/05 |
07:00 |
| Avalo Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Updates |
Globe Newswire |
11/05 |
07:00 |
| Lifetime Brands, Inc. Reports Third Quarter 2026 Financial Results |
Globe Newswire |
11/05 |
07:00 |
| Gain Therapeutics Announces Late-Breakers and Poster Presentations at Upcoming Scientific Conferences |
Globe Newswire |
11/05 |
07:00 |
| Resolute Holdings Reports Third Quarter 2026 Results |
Globe Newswire |
11/05 |
07:00 |
| Keel Infrastructure Reports Third Quarter 2026 Results |
Globe Newswire |
11/05 |
07:00 |
| Lithium Ionic Files Statement of Defence, Crossclaim, Counterclaim and Third-Party Claim in Emerita Resources Litigation |
Globe Newswire |
11/05 |
07:00 |
| Cartesian Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update |
Globe Newswire |
11/05 |
07:00 |
| Lexicon Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Clinical Updates |
Globe Newswire |
11/05 |
07:00 |
| INVE Technologies Sets Third Quarter 2026 Earnings Call for Thursday, November 12, 2026, at 5:00 PM EST |
Globe Newswire |
11/05 |
07:00 |
